Emcure Pharmaceuticals Allots 7,700 Equity Shares Under ESOP Scheme

Emcure Pharmaceuticals Limited has announced the allotment of 7,700 equity shares, each with a face value of ₹10, pursuant to the exercise of options under the Emcure - Employee Stock Option Scheme 20...

Emcure Pharmaceuticals Limited has announced the allotment of 7,700 equity shares, each with a face value of ₹10, pursuant to the exercise of options under the Emcure - Employee Stock Option Scheme 2013. The decision was unanimously approved by the Nomination and Remuneration Committee of the Board of Directors via a resolution by circulation, passed on December 16, 2025. This allotment will result in an increase in the company's issued and paid-up share capital. The number of equity shares has increased from 18,95,64,847 to 18,95,72,547, with the total paid-up share capital rising from ₹189,56,48,470 to ₹1,89,57,25,470. The newly allotted equity shares will rank pari passu with the existing equity shares of the company in all respects.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Emcure Pharmaceuticals Limited in the news today?

Emcure Pharmaceuticals Limited (EMCURE) is in the news due to the announcement is a routine allotment of shares under an existing esop scheme and does not have a significant positive or negative financial impact on the company.

Designated Person Disclosures
Emcure Pharmaceuticals LimitedEMCUREhttps://prysm.fi/v2/analyze/EMCURE

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Emcure Pharmaceuticals Allots 7,700 Equity Shares Under ESOP Scheme

December 16, 2025, 04:39 PM

AI Sentiment Analysis

Emcure Pharmaceuticals Limited has announced the allotment of 7,700 equity shares, each with a face value of ₹10, pursuant to the exercise of options under the Emcure - Employee Stock Option Scheme 2013. The decision was unanimously approved by the Nomination and Remuneration Committee of the Board of Directors via a resolution by circulation, passed on December 16, 2025.

This allotment will result in an increase in the company's issued and paid-up share capital. The number of equity shares has increased from 18,95,64,847 to 18,95,72,547, with the total paid-up share capital rising from ₹189,56,48,470 to ₹1,89,57,25,470. The newly allotted equity shares will rank pari passu with the existing equity shares of the company in all respects.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained - “Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

Top Queries to Ask About Emcure Pharmaceuticals Limited

More News on Emcure Pharmaceuticals Limited

Discover more trending news on Prysm

View All